An observational study on monoclonal antibodies against calcitonin‐gene‐related peptide and its receptor
出版年份 2023 全文链接
标题
An observational study on monoclonal antibodies against calcitonin‐gene‐related peptide and its receptor
作者
关键词
-
出版物
EUROPEAN JOURNAL OF NEUROLOGY
Volume 30, Issue 6, Pages 1764-1773
出版商
Wiley
发表日期
2023-03-01
DOI
10.1111/ene.15761
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study
- (2022) Raffaele Ornello et al. JOURNAL OF HEADACHE AND PAIN
- Maintenance of response and predictive factors of 1‐year GalcanezumAb treatment in real‐life migraine patients in Italy : The multicenter prospective cohort GARLIT study
- (2022) Fabrizio Vernieri et al. EUROPEAN JOURNAL OF NEUROLOGY
- Migraine therapeutics differentially modulate the CGRP pathway
- (2021) Minoti Bhakta et al. CEPHALALGIA
- Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)
- (2021) Fabrizio Vernieri et al. JOURNAL OF HEADACHE AND PAIN
- Efficacy and Safety of Monoclonal Antibody Against Calcitonin Gene-Related Peptide or Its Receptor for Migraine: A Systematic Review and Network Meta-analysis
- (2021) Xing Wang et al. Frontiers in Pharmacology
- Timing and durability of response to erenumab in patients with chronic migraine
- (2021) Stewart J. Tepper et al. HEADACHE
- Network meta-analysis on efficacy and safety of different anti-CGRP monoclonal antibody regimens for prophylaxis and treatment of episodic migraine
- (2021) Min Shi et al. NEUROLOGICAL RESEARCH
- Predictors of response to erenumab after 12 months of treatment
- (2021) Carlo Baraldi et al. Brain and Behavior
- Effect of antibody switch in non-responders to a CGRP receptor antibody treatment in migraine: A multi-center retrospective cohort study
- (2021) Lucas Hendrik Overeem et al. CEPHALALGIA
- Efficacy and safety of anti-calcitonin gene-related peptide monoclonal antibodies for treatment of chronic migraine: A systematic review and network meta-analysis
- (2021) Prashant Soni et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3‐month observational, longitudinal, cohort, multicenter, Italian real‐life study
- (2021) Fabrizio Vernieri et al. EUROPEAN JOURNAL OF NEUROLOGY
- Clinic and genetic predictors in response to erenumab
- (2021) Chiara Zecca et al. EUROPEAN JOURNAL OF NEUROLOGY
- Real‐World Patient Experience With Erenumab for the Preventive Treatment of Migraine
- (2020) Jennifer Robblee et al. HEADACHE
- LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF FREMANEZUMAB IN MIGRAINE: A RANDOMIZED STUDY
- (2020) Peter J. Goadsby et al. NEUROLOGY
- Efficacy and safety of erenumab (AMG334) in episodic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study
- (2019) Peter J Goadsby et al. CEPHALALGIA
- Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial
- (2018) Vladimir Skljarevski et al. CEPHALALGIA
- ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
- (2018) David W Dodick et al. CEPHALALGIA
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
- (2018) CEPHALALGIA
- Evaluation of Galcanezumab for the Prevention of Episodic Migraine
- (2018) Virginia L. Stauffer et al. JAMA Neurology
- CGRP, Amylin, Immunology, and Headache Medicine
- (2018) Frederick R. Taylor HEADACHE
- Galcanezumab in chronic migraine
- (2018) Holland C. Detke et al. NEUROLOGY
- Blocking CGRP in migraine patients – a review of pros and cons
- (2017) Marie Deen et al. JOURNAL OF HEADACHE AND PAIN
- Endosomal signaling of the receptor for calcitonin gene-related peptide mediates pain transmission
- (2017) Rebecca E. Yarwood et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles
- (2016) Debbie L. Hay et al. Annual Review of Pharmacology and Toxicology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search